To content

TOP > J-PRECOR > PURPOSE

PURPOSE

Due to the trend of internationalization, travel clinics have been established in various regions of Japan to provide vaccinations and prescriptions of prophylactic medication to travelers. However, there is a lack of data on travelers’ characteristics and their vaccine needs in Japan.

This study aimed to understand the characteristics of pre-travel consultations in Japan by collecting data on the contents of travel consultations, including vaccines and prophylactic medication, provided in response to travel details at multi-center travel clinics.

Another objective is to investigate standard practices for the content of pre-travel consultations and to promote the equalization of the quality of travel consultations in Japan. To assist in equalizing quality, we will create a medical support tool that combines the obtained data. At the same time, we will develop a web-based tool that can provide support for pre-travel consultations. We hope to compare our practices with those of other institutions and review our practices through this tool.

History

April 2017
Research: “Establishment of a multi-center network for a pre-travel consultation registry and development and use of medical support tools (Principal investigator: Kei Yamamoto),” started and supported by National Center for Global Health and Medicines.
February 2018
Registration started in six institutes.
April 2020
Continued research as a special project of the National Center for Global Health and Medicines.

Subject:

Subjects were clients who came to the research institute for pre-travel consultation.

Exclusion criteria:

  1. Clients who do not plan to travel abroad.
  2. Clients who have received pre-travel consultation at institutions other than the research institute and do not wish to receive it at the research institute.

Registered facility conditions:

  1. General hospitals that offer pre-travel consultation.
  2. At least 50 new cases of pre-travel consultation per year.

Informed consent:

Substitute for obtaining consent by disclosing information in a public information document and opting out.

Methods:

Register information obtained from regular pre-travel consultation in a proprietary web registry

Research institutes (Prefecture) on 1 January 2022:

National Center for Global Health and Medicine (Tokyo); Nara Seibu Hospital (Nara); Kenwakai Otemachi Hospital (Fukuoka); Osaka City General Hospital (Osaka); Kyoto City Hospital (Kyoto); Shinshu University Hospital (Nagano); Hamamatsu Medical Center (Shizuoka); Rinku General Medical Center (Osaka); Kyushu University Hospital (Fukuoka); Tottori University Hospital (Tottori); Japanese Red Cross Society Wakayama Medical Center (Wakayama); Sapporo City General Hospital (Hokkaido); Yamanashi Prefectural Central Hospital (Yamanashi); Fukuyama City Hospital (Hiroshima); Aso Iizuka Hospital (Fukuoka), Toyama University Hospital (Toyama); Nara Medical University Hospital (Nara)